Loading...
XASX
ADR
Market cap2mUSD
Jun 18, Last price  
0.00AUD
1D
0.00%
1Q
0.00%
Jan 2017
-99.94%
IPO
-99.98%
Name

Adherium Ltd

Chart & Performance

D1W1MN
XASX:ADR chart
P/E
—
P/S
4.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
100.02%
Rev. gr., 5y
-21.26%
Revenues
817k
-2.82%
559,525480,9332,907,0002,100,8002,347,0005,867,0002,779,0002,218,000401,000529,0003,195,000840,982817,237
Net income
-13m
L+24.01%
-138,506-2,206,911-1,255,000-6,308,000-12,810,000-9,338,000-11,794,000-11,397,000-15,036,000-10,044,000-9,858,000-10,224,173-12,679,349
CFO
-10m
L-5.93%
0-2,161,61123,000-7,913,000-11,581,000-9,824,000-11,807,000-7,317,000-11,273,000-9,610,000-9,278,000-10,613,012-9,983,703

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Adherium Limited specializes in developing, manufacturing, and providing advanced digital health solutions. The company's core mission is to enhance medication adherence for individuals managing chronic conditions in key international markets, spanning New Zealand, Australia, Europe, North America, and Asia. A central offering is Hailie, a comprehensive system engineered to optimize medication use for patients suffering from chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD). This innovative solution integrates Bluetooth-enabled Hailie sensors, which discreetly attach to patients' inhalers to deliver immediate feedback. The Hailie ecosystem is further supported by an intuitive mobile application and a dedicated online portal. Established in 2001, Adherium Limited is headquartered in Auckland, New Zealand.
URL
https://www.adherium.com/
IPO date
Aug 26, 2015
Employees
Domiciled in
NZ
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT